Glendon E. French III, Director at Pulmonx Corp (LUNG), sold 110,906 shares at $8.14 ($918K) on 2025-02-20, disclosed to the SEC on 2025-02-24.
Scheduled sale ($918k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.14 | 43,036 | $350K | 38.2% |
| 2 | $8.14 | 43,036 | $350K | 38.2% |
| 3 | $8.76 | 12,417 | $109K | 11.8% |
| 4 | $8.76 | 12,417 | $109K | 11.8% |
| Total | $8.28 avg | 110,906 | $918K | 100% |
| Filing → |
| LUNG | SELL | 2026-03-04 | $97K | — | Filing → |
| LUNG | SELL | 2025-12-03 | $14K | — | Filing → |
| LUNG | SELL | 2025-03-21 | $157K | — | Filing → |